I now have all the information needed for a comprehensive answer. Let me compile the complete response.
Malaria - Complete Overview
Source: Harrison's Principles of Internal Medicine 22E (2025, McGraw Hill Medical), Chapter 231
1. Organism of Malaria (1 mark)
Malaria is caused by protozoan parasites of the genus Plasmodium, transmitted to humans through the bite of an infected female Anopheles mosquito.
Six species cause human malaria:
| Species | Key Feature |
|---|
| P. falciparum | Most deadly; causes >80% of infections and 90% of deaths in sub-Saharan Africa; can invade any erythrocyte |
| P. vivax | Common in Central/South America and Asia; forms dormant hypnozoites causing relapses |
| P. ovale (curtisi & wallikeri) | Two morphologically identical sympatric species; also forms hypnozoites |
| P. malariae | Found in most endemic areas; 72-hour erythrocytic cycle |
| P. knowlesi | Monkey malaria parasite; found in Southeast Asia; can cause severe disease |
| P. simium / P. cynomolgi | Occasional human infections from monkey reservoirs |
P. falciparum is the most dangerous. P. vivax and P. ovale cause relapses due to dormant liver forms called hypnozoites.
2. Signs and Symptoms of Malaria (5 marks)
Classic Presentation
The typical malarial attack occurs in three stages:
- Cold stage - sudden onset of shaking chills, rigors
- Hot stage - high fever (up to 40-41°C), headache, flushing
- Sweating stage - profuse sweating, temperature returns to normal, patient feels exhausted
Common Symptoms
- Fever - classically periodic: every 48 hours (tertian) in P. vivax/ovale, every 72 hours (quartan) in P. malariae; irregular in early P. falciparum
- Headache - often severe
- Myalgia and arthralgia - generalized body pains
- Malaise and fatigue
- Nausea, vomiting, anorexia
- Abdominal pain and diarrhea
- Pallor - due to hemolytic anemia
- Splenomegaly - in repeated or chronic infections
- Hepatomegaly with mild jaundice
Signs/Symptoms of Severe (Falciparum) Malaria
| Manifestation | Description |
|---|
| Cerebral malaria | Unarousable coma, Glasgow Coma Score <11; diffuse symmetric encephalopathy; seizures (~50% of children) |
| Severe anemia | Hematocrit <15% or Hgb <5 g/dL; normochromic, normocytic |
| Acidosis | Arterial pH <7.25, deep labored "respiratory distress" breathing |
| Hypoglycemia | Blood glucose <2.2 mmol/L; especially in children and pregnant women |
| Acute kidney injury | Oliguria, rising creatinine |
| Pulmonary edema / ARDS | Oxygen saturation <92%, very high mortality |
| Abnormal bleeding / DIC | Spontaneous bleeding, petechiae |
| Hyperparasitemia | >5% parasitized RBCs; poor prognostic sign |
| Hemoglobinuria (blackwater fever) | Massive intravascular hemolysis; dark/black urine |
| Prostration | Inability to sit unaided in older children/adults |
| Jaundice | Bilirubin >50 mmol/L; hemolytic + hepatic components |
3. Prevention of Malaria (5 marks)
A. Personal Protection Against Mosquito Bites
- Insect repellents: DEET 10-35% applied to exposed skin (or 7% picaridin if DEET is not tolerated)
- Insecticide-treated bed nets (ITNs): Long-lasting ITNs (LLINs) treated with pyrethroids - reduce all-cause child mortality in Africa by ~20%. Newer nets combine pyrethroids with chlorfenapyr or pyriproxyfen to counter insecticide resistance
- Protective clothing: Long sleeves and trousers, especially from dusk to dawn (peak mosquito feeding time)
- Indoor residual spraying (IRS): Spraying homes with insecticides as part of integrated vector control programs
B. Environmental / Vector Control
- Elimination of mosquito breeding sites (standing water, swamps)
- Larviciding - treating water bodies to kill larvae
- Biological control methods
C. Chemoprophylaxis (for travelers and high-risk groups)
| Drug | Regimen | Area |
|---|
| Atovaquone-proguanil | Daily, start 1-2 days before travel, stop 7 days after | All areas including chloroquine-resistant regions |
| Mefloquine | Weekly, start 2-3 weeks before travel | Most endemic areas |
| Doxycycline | Daily | Chloroquine/mefloquine-resistant areas |
| Chloroquine | Weekly | Chloroquine-sensitive areas only |
| Primaquine | Daily | P. vivax-endemic areas; requires G6PD testing first |
D. Intermittent Preventive Treatment (IPT)
- IPTp - Intermittent preventive treatment in pregnant women (sulfadoxine-pyrimethamine each antenatal visit after 1st trimester)
- IPTi - In infants at immunization visits
- Seasonal malaria chemoprevention (SMC) - In high-transmission Sahel regions, children 3 months to 5 years receive monthly amodiaquine + SP during peak transmission season
E. Vaccination
- RTS,S/AS01 (Mosquirix) and RTS,S/Matrix-M - Pre-erythrocytic vaccines recommended by WHO for deployment in young children in endemic areas; provide partial, relatively short-duration protection against P. falciparum
- An irradiated live sporozoite vaccine (PfSPZ) is in late-stage development
4. Antimalarial Drugs (2 marks)
Major Classes
1. Artemisinin Derivatives (first-line)
- Artesunate (IV/IM - drug of choice for severe malaria)
- Artemether (IM)
- Dihydroartemisinin (oral)
- Mechanism: produce free radicals that damage parasite proteins; act on all erythrocytic stages
2. Artemisinin-Based Combination Therapies (ACTs) - WHO first-line for uncomplicated falciparum malaria
- Artemether-lumefantrine
- Artesunate-mefloquine
- Dihydroartemisinin-piperaquine
- Artesunate-amodiaquine
- Artesunate-sulfadoxine-pyrimethamine
- Artesunate-pyronaridine
3. 4-Aminoquinolines
- Chloroquine - for P. vivax, P. ovale, P. malariae (and rare chloroquine-sensitive P. falciparum); acts by inhibiting heme detoxification
- Amodiaquine - used as ACT partner drug
4. Quinoline Methanols
- Quinine / Quinidine - for severe malaria when artesunate unavailable; IV quinine dihydrochloride
- Mefloquine - oral; used for prophylaxis and as ACT partner
5. 8-Aminoquinolines
- Primaquine - only drug active against hepatic hypnozoites (radical cure of P. vivax/P. ovale); also a gametocytocide; requires G6PD screening before use
- Tafenoquine - once-weekly single-dose alternative to primaquine for P. vivax radical cure
6. Antifolates
- Pyrimethamine + Sulfadoxine (SP / Fansidar) - used in IPTp for pregnant women; resistance widespread
- Proguanil - mainly used in combination with atovaquone
7. Hydroxynaphthoquinone
- Atovaquone-Proguanil (Malarone) - highly effective causal prophylaxis and treatment; acts on mitochondrial electron transport; expensive
8. Tetracyclines (used as partner drugs, not alone)
- Doxycycline - prophylaxis and combination treatment; avoid in pregnancy and children <8 years
- Tetracycline - similar use
Key Points to Remember:
- WHO recommends ACT as first-line for all uncomplicated P. falciparum malaria
- IV Artesunate is the drug of choice for severe malaria (35% mortality reduction vs. quinine in Asian adults)
- Primaquine is the only agent that achieves radical cure for P. vivax and P. ovale by eliminating hepatic hypnozoites
- Artemisinin resistance has emerged in Southeast Asia (Greater Mekong Subregion) and is now appearing in East Africa - a major global health threat
Harrison's Principles of Internal Medicine 22E (2025), Chapter 231: Malaria